In CHB and HBV-HCC patients respectively, the co-expression of TIGIT and PD-1 or TIGIT and TIM-3 on NK cells is also elevated, and these specific subsets of NK cells display impaired function (157, 159). The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.